(2R,3R,4S,5S,6R)-2-[(1R,2R)-10-(4-hydroxy-5,6-dimethoxy-3-methyl-2-pyridyl)-1-[3-hydroxy-1-methyl-prop-1-enyl]-2,4,8-trimethyl-deca-3,5,8-trienoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol

ID: ALA4464303

PubChem CID: 101428705

Max Phase: Preclinical

Molecular Formula: C31H47NO10

Molecular Weight: 593.71

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1nc(C/C=C(\C)C/C=C/C(C)=C/[C@@H](C)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)/C(C)=C/CO)c(C)c(O)c1OC

Standard InChI:  InChI=1S/C31H47NO10/c1-17(11-12-22-21(5)24(35)29(39-6)30(32-22)40-7)9-8-10-18(2)15-20(4)28(19(3)13-14-33)42-31-27(38)26(37)25(36)23(16-34)41-31/h8,10-11,13,15,20,23,25-28,31,33-34,36-38H,9,12,14,16H2,1-7H3,(H,32,35)/b10-8+,17-11+,18-15+,19-13+/t20-,23-,25-,26+,27-,28+,31+/m1/s1

Standard InChI Key:  ZNDBGWYPOYJCKZ-FJCIJDQSSA-N

Molfile:  

 
     RDKit          2D

 43 44  0  0  0  0  0  0  0  0999 V2000
   19.3132   -5.0265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3121   -5.8419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0160   -6.2508    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7256   -5.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7228   -5.0229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0142   -4.6217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0118   -3.8087    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4248   -4.6157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4299   -6.2489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1328   -5.8392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8370   -6.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5400   -5.8370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2442   -6.2445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9471   -5.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6555   -6.2422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6568   -7.0553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3295   -5.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0626   -6.2400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7656   -5.8303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4698   -6.2378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1727   -5.8281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8770   -6.2356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4711   -7.0508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7932   -4.6747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.0601   -4.1227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0633   -3.3075    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.3632   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6578   -3.3063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6571   -4.1204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3618   -4.5323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3329   -5.1926    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.9495   -4.5289    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.9501   -2.9019    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.3632   -2.0912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6596   -1.6827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.0639   -7.0531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8383   -7.0597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6082   -6.2499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.6075   -7.0630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6095   -4.6222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.6093   -3.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8464   -3.9044    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   30.5851   -5.8277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  5  8  1  0
  4  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 20 23  1  0
 19 24  1  1
 25 24  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 25 30  1  0
 30 31  1  6
 29 32  1  1
 28 33  1  6
 27 34  1  1
 34 35  1  0
 18 36  1  6
 11 37  1  0
  2 38  1  0
 38 39  1  0
  1 40  1  0
 40 41  1  0
 25 42  1  6
 22 43  1  0
M  END

Associated Targets(Human)

786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OS-RC-2 (487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HK-2 (249 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1H3 Tchem LXR-alpha (2891 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa S3 (477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H69 (709 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P388/ADM (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 593.71Molecular Weight (Monoisotopic): 593.3200AlogP: 2.25#Rotatable Bonds: 14
Polar Surface Area: 171.19Molecular Species: NEUTRALHBA: 11HBD: 6
#RO5 Violations: 3HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.88CX Basic pKa: 2.94CX LogP: 2.33CX LogD: 2.33
Aromatic Rings: 1Heavy Atoms: 42QED Weighted: 0.14Np Likeness Score: 2.01

References

1. Zhou X, Liang Z, Li K, Fang W, Tian Y, Luo X, Chen Y, Zhan Z, Zhang T, Liao S, Liu S, Liu Y, Fenical W, Tang L..  (2019)  Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1.,  62  (15): [PMID:31298537] [10.1021/acs.jmedchem.9b00598]
2. Liang Z, Chen Y, Gu T, She J, Dai F, Jiang H, Zhan Z, Li K, Liu Y, Zhou X, Tang L..  (2021)  LXR-Mediated Regulation of Marine-Derived Piericidins Aggravates High-Cholesterol Diet-Induced Cholesterol Metabolism Disorder in Mice.,  64  (14.0): [PMID:34251816] [10.1021/acs.jmedchem.1c00175]
3. Govindarajan M..  (2018)  Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.,  143  [PMID:29126728] [10.1016/j.ejmech.2017.10.015]

Source